Avamab
Brand Name: Avamab
Generic Name: Bevacizumab
Active
Registration Number
BR-1386
Dosage Form
Concentrate for Solution for Infusion (IV)
Issuance Date
February 2, 2022
Expiry Date
February 2, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100 mg/4 mL (25 mg/mL)
Packaging5 mL (Net content: 4 mL) Type I borosilicate colorless glass vial with chlorobutyl rubber stopper, crimped with aluminum seal fitted with plastic flip-off cap (Box of l's)
Classification
C
Classification
Prescription Drug (Rx)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
BevacizumabActive
Monograph: Bevacizumab